Economic evaluation of finotonlimab plus bevacizumab as first-line therapy for advanced hepatocellular carcinoma
Table 7
ICER values at different discount rates for drug prices.
Click through the PLOS taxonomy to find articles in your field.
For more information about PLOS Subject Areas, click here.
ICER values at different discount rates for drug prices.